GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_4600/2025

Pfizer SA, Pfizer Luxembourg S.a.r.l., Laboratórios Pfizer, Lda., Pfizer Pharma GmbH, Pfizer Aps, Pfizer B.V., Pfizer S.r.l., Pfizer Oy, Pfizer Corporation Austria GmbH, Pfizer Service Company S.r.l., Pfizer AB, Pfizer Manufacturing Belgium NV, Pfizer SAS, Pfizer Europe MA EEIG

Date
2025-03-04
Division
Düsseldorf (DE) Local Division
Type of action
Generic application
Language
EN

Metadata

Case IDORD_4600-2025-8467915d04fa
Case number
Registry numberORD_4600/2025
Order referenceORD_4600/2025
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 6

1 Düsseldorf Local Division UPC_CFI_468/2024 UPC_CFI_687/2024 Procedural Order of the Court of First Instance of the Unified Patent Court issued on 4 March 2025 concerning EP 4 183 412 CLAIMANT: GlaxoSmithKline Biologicals SA, Rue de l’Institut 89, 1330 Rixensart, Belgium, Represented by: Attorney at law Oliver Jan Jüngst, Attorney at law Luca Brons, Bird & Bird LLP, Carl-Theodor-Straße 6, 40213 Düsseldorf, Germany, Participating: Patent Attorney Dr. Daniela Kinkeldey, Patent Attorney Dr. Ann a Schadel, Bird & Bird LLP, Maximiliansplatz 22, 80333 Munich, Germany, Electronic address for service: oliver.jan.juengst@twobirds.com DEFENDANTS: 1. Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Ixelles, Belgium, 2. Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium, 3. Pfize ...